Cargando…

Efficacy of local dexmedetomidine add-on for spermatic cord block anesthesia in patients undergoing intrascrotal surgeries: randomized controlled multicenter clinical trial

STUDY OBJECTIVE: The objective of this study was to evaluate the effect of adding dexmedetomidine (DEX) to bupivacaine on the quality of spermatic cord block anesthesia and postoperative analgesia. DESIGN: This is a randomized, double-blind study. SETTING: This study was performed in an educational...

Descripción completa

Detalles Bibliográficos
Autores principales: Hetta, Diab Fuad, Kamal, Emad E, Mahran, Ali M, Ahmed, Doaa G, Elawamy, Abdelraheem, Abdelraouf, Abdelraouf MS
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687449/
https://www.ncbi.nlm.nih.gov/pubmed/29184438
http://dx.doi.org/10.2147/JPR.S145305
_version_ 1783278961354080256
author Hetta, Diab Fuad
Kamal, Emad E
Mahran, Ali M
Ahmed, Doaa G
Elawamy, Abdelraheem
Abdelraouf, Abdelraouf MS
author_facet Hetta, Diab Fuad
Kamal, Emad E
Mahran, Ali M
Ahmed, Doaa G
Elawamy, Abdelraheem
Abdelraouf, Abdelraouf MS
author_sort Hetta, Diab Fuad
collection PubMed
description STUDY OBJECTIVE: The objective of this study was to evaluate the effect of adding dexmedetomidine (DEX) to bupivacaine on the quality of spermatic cord block anesthesia and postoperative analgesia. DESIGN: This is a randomized, double-blind study. SETTING: This study was performed in an educational and research hospital. PATIENTS: One hundred twenty adult males were scheduled for intrascrotal surgeries. INTERVENTIONS: Patients were divided into two groups: group B received 10 mL of bupivacaine 0.25% for spermatic cord block and intravenous 50 µg of DEX and group BD received 10 mL of bupivacaine 0.25% added to 50 µg of DEX (9.5 mL bupivacaine 0. 25% + 0.5 mL [50 µg] DEX) for spermatic cord block, and for masking purposes, the patients received isotonic saline intravenously. MEASUREMENTS: Time to first analgesic request, analgesic consumption, and visual analog scale (VAS) pain score in the first 24 hours postoperatively were assessed. MAIN RESULTS: Time to first rescue analgesic was significantly delayed in group BD in comparison with group B, median (interquartile) range, 7 (6–12) hours versus 6 (5–7) hours, (p=0.000), the mean cumulative morphine consumption (mg) in the first postoperative 24 hours was significantly lower in group BD compared with group B, 8.13±4.45 versus 12.7±3.79, with a mean difference (95% CI) of −4.57 (−6.06 to −3.07) (p=0.000); also, there was a significant reduction of VAS pain score in group BD in comparison with group B at all measured time points, VAS 2 hours (1.28±0.9 vs 1.92±0.8), VAS 6 hours (2.62±1.5 vs 3.93±1.2), VAS 12 hours (2.40±1.1 vs 3.57±0.65), VAS 24 hours (1.90±0.68 vs 2.53±0.62) (p=0.000) CONCLUSION: The addition of 50 µg of DEX to bupivacaine 0.25% in spermatic cord block for intrascrotal surgeries resulted in delay of first analgesic supplementation, reduction of postoperative analgesic consumption as well as improvement of the success rate of the block.
format Online
Article
Text
id pubmed-5687449
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-56874492017-11-28 Efficacy of local dexmedetomidine add-on for spermatic cord block anesthesia in patients undergoing intrascrotal surgeries: randomized controlled multicenter clinical trial Hetta, Diab Fuad Kamal, Emad E Mahran, Ali M Ahmed, Doaa G Elawamy, Abdelraheem Abdelraouf, Abdelraouf MS J Pain Res Original Research STUDY OBJECTIVE: The objective of this study was to evaluate the effect of adding dexmedetomidine (DEX) to bupivacaine on the quality of spermatic cord block anesthesia and postoperative analgesia. DESIGN: This is a randomized, double-blind study. SETTING: This study was performed in an educational and research hospital. PATIENTS: One hundred twenty adult males were scheduled for intrascrotal surgeries. INTERVENTIONS: Patients were divided into two groups: group B received 10 mL of bupivacaine 0.25% for spermatic cord block and intravenous 50 µg of DEX and group BD received 10 mL of bupivacaine 0.25% added to 50 µg of DEX (9.5 mL bupivacaine 0. 25% + 0.5 mL [50 µg] DEX) for spermatic cord block, and for masking purposes, the patients received isotonic saline intravenously. MEASUREMENTS: Time to first analgesic request, analgesic consumption, and visual analog scale (VAS) pain score in the first 24 hours postoperatively were assessed. MAIN RESULTS: Time to first rescue analgesic was significantly delayed in group BD in comparison with group B, median (interquartile) range, 7 (6–12) hours versus 6 (5–7) hours, (p=0.000), the mean cumulative morphine consumption (mg) in the first postoperative 24 hours was significantly lower in group BD compared with group B, 8.13±4.45 versus 12.7±3.79, with a mean difference (95% CI) of −4.57 (−6.06 to −3.07) (p=0.000); also, there was a significant reduction of VAS pain score in group BD in comparison with group B at all measured time points, VAS 2 hours (1.28±0.9 vs 1.92±0.8), VAS 6 hours (2.62±1.5 vs 3.93±1.2), VAS 12 hours (2.40±1.1 vs 3.57±0.65), VAS 24 hours (1.90±0.68 vs 2.53±0.62) (p=0.000) CONCLUSION: The addition of 50 µg of DEX to bupivacaine 0.25% in spermatic cord block for intrascrotal surgeries resulted in delay of first analgesic supplementation, reduction of postoperative analgesic consumption as well as improvement of the success rate of the block. Dove Medical Press 2017-11-08 /pmc/articles/PMC5687449/ /pubmed/29184438 http://dx.doi.org/10.2147/JPR.S145305 Text en © 2017 Hetta et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Hetta, Diab Fuad
Kamal, Emad E
Mahran, Ali M
Ahmed, Doaa G
Elawamy, Abdelraheem
Abdelraouf, Abdelraouf MS
Efficacy of local dexmedetomidine add-on for spermatic cord block anesthesia in patients undergoing intrascrotal surgeries: randomized controlled multicenter clinical trial
title Efficacy of local dexmedetomidine add-on for spermatic cord block anesthesia in patients undergoing intrascrotal surgeries: randomized controlled multicenter clinical trial
title_full Efficacy of local dexmedetomidine add-on for spermatic cord block anesthesia in patients undergoing intrascrotal surgeries: randomized controlled multicenter clinical trial
title_fullStr Efficacy of local dexmedetomidine add-on for spermatic cord block anesthesia in patients undergoing intrascrotal surgeries: randomized controlled multicenter clinical trial
title_full_unstemmed Efficacy of local dexmedetomidine add-on for spermatic cord block anesthesia in patients undergoing intrascrotal surgeries: randomized controlled multicenter clinical trial
title_short Efficacy of local dexmedetomidine add-on for spermatic cord block anesthesia in patients undergoing intrascrotal surgeries: randomized controlled multicenter clinical trial
title_sort efficacy of local dexmedetomidine add-on for spermatic cord block anesthesia in patients undergoing intrascrotal surgeries: randomized controlled multicenter clinical trial
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687449/
https://www.ncbi.nlm.nih.gov/pubmed/29184438
http://dx.doi.org/10.2147/JPR.S145305
work_keys_str_mv AT hettadiabfuad efficacyoflocaldexmedetomidineaddonforspermaticcordblockanesthesiainpatientsundergoingintrascrotalsurgeriesrandomizedcontrolledmulticenterclinicaltrial
AT kamalemade efficacyoflocaldexmedetomidineaddonforspermaticcordblockanesthesiainpatientsundergoingintrascrotalsurgeriesrandomizedcontrolledmulticenterclinicaltrial
AT mahranalim efficacyoflocaldexmedetomidineaddonforspermaticcordblockanesthesiainpatientsundergoingintrascrotalsurgeriesrandomizedcontrolledmulticenterclinicaltrial
AT ahmeddoaag efficacyoflocaldexmedetomidineaddonforspermaticcordblockanesthesiainpatientsundergoingintrascrotalsurgeriesrandomizedcontrolledmulticenterclinicaltrial
AT elawamyabdelraheem efficacyoflocaldexmedetomidineaddonforspermaticcordblockanesthesiainpatientsundergoingintrascrotalsurgeriesrandomizedcontrolledmulticenterclinicaltrial
AT abdelraoufabdelraoufms efficacyoflocaldexmedetomidineaddonforspermaticcordblockanesthesiainpatientsundergoingintrascrotalsurgeriesrandomizedcontrolledmulticenterclinicaltrial